US Edition
Published • loading... • Updated
DFE Pharma launches EcoLact 2030 for lactose excipients
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
DFE Pharma launches EcoLact 2030 for lactose excipients
DFE Pharma has launched EcoLact 2030, an initiative focused on providing transparency and verified sustainability data for its lactose portfolio. The programme enables pharmaceutical manufacturers to access auditable CO₂ data and full value-chain traceability, allowing them to report Scope 3 emission reductions without changes to existing operations. Pharmaceutical companies are required to meet climate and ESG targets, including Scope 3 emissio…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
